Karen Winkfield | |
|---|---|
| Born | 1970 (age 53–54) |
| Alma mater | Binghamton University Duke University School of Medicine |
| Scientific career | |
| Fields | Radiation oncology, health equity |
| Institutions | Atrium Health Wake Forest Baptist Vanderbilt University |
| Website | drkarenwinkfield |
Karen Marie Winkfield (born 1970) is an American radiation oncologist, physician-scientist, and implementation scientist. She is the Ingram Professor of Cancer Research at Vanderbilt University School of Medicine.
Early life and education
Winkfield was born in 1970[1] to a family of Jehovah's Witnesses who were opposed to formal education.[2]
Winkfield completed a B.S. in biochemistry at Binghamton University. She earned a Ph.D. (2004) in pathology and M.D. (2005) from Duke University School of Medicine.[3][4] Winkfield was the second black woman to complete the medical scientist training program at Duke University.[4] She completed a radiation oncology residency at Harvard University.[5]
Career
Winfield was an associate director for community outreach and engagement and director of the office of cancer health equity at Atrium Health Wake Forest Baptist.[5] In 2020, Winkfield joined Vanderbilt University.[5] She is the executive director of the Meharry-Vanderbilt Alliance, Ingram Professor of Cancer Research, and a professor of radiation oncology at Vanderbilt University Medical Center.[3]
Winkfield is the cofounder and director of the Association of Black Radiation Oncologists.[5] She is an implementation scientist focused on using her experience with community engagement to improve health equity. Winkfield co-leads the Inclusive Participation Workgroup of the NIH CEAL teams against COVID-19 disparities.[6]
In September 2021, Winkfield was appointed by U.S. president Joe Biden to a six-year term on the National Cancer Advisory Board.[5][6] She was also recognized as one of the 100 Influential Women in Oncology by OncoDaily.[7]
Personal life
Winkfield was married to Jeffrey Walker. Walker was diagnosed with type 2 diabetes in 2003 and passed away in 2018 from complications of the disease. His medical journey influenced Winkfield to pursue patient advocacy.[2]
See also
References
- ^ "VIAF". Virtual International Authority File. Retrieved 2021-09-25.
- ^ a b Watson, Stephanie (September 25, 2018). "Karen M. Winkfield, MD, PhD: 2018 Health Heroes, Advocate". WebMD. Retrieved 2021-09-26.
- ^ a b "Winkfield [193101] | Vanderbilt-Ingram Cancer Center". www.vicc.org. Retrieved 2021-09-26.
- ^ a b "Karen Winkfield, PhD'04, MD'05, HS'05-'06 | Duke School of Medicine". medschool.duke.edu. Archived from the original on 2021-09-26. Retrieved 2021-09-26.
- ^ a b c d e Wilemon, Tom (2021-09-18). "President Biden Appoints MVA Executive Director to National Cancer Advisory Board". The Tennessee Tribune. Retrieved 2021-09-26.
- ^ a b "President Biden Appoints Members to National Cancer Advisory Board". The White House. 2021-09-15. Retrieved 2021-09-26.
This article incorporates text from this source, which is in the public domain.
- ^ "100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023". oncodaily.com. 14 October 2023.
External links
- Official website
- Karen Winkfield's publications indexed by the Scopus bibliographic database. (subscription required)
| International | |
|---|---|
| National | |
| Academics | |
This page was last edited on 7 April 2024, at 10:27